IRIS Kinetics Unveils Point-of-Care Kinetic Biosensing Platform
The IRIS TX-100 uses cartridge-based technology to measure up to 100 biomarkers in approximately 10 minutes.
Category: Company News
Company News
Latest
Company News
Latest
Anthem to Cover Quanterix’s LucentAD Complete Alzheimer’s Blood Test
The insurer will provide coverage for the multi-analyte test starting July 2026, following new data showing parity with mass spectrometry.
Company News
Latest
Stanford Blood Center Launches Infectious Disease Testing for Organ and Tissue Donors
The new service supports transplantation medicine for 13 million people across Northern California and Northern Nevada.
Pictor Holdings Secures $7.5 Million to Expand Protein Analysis Platform
The funding will support manufacturing and commercial partnerships for a system that analyzes multiple protein targets in less than two hours.
Read More
InterVenn, Aranscia Expand Access to Blood-Based Ovarian Cancer Test
The expanded commercialization agreement aims to increase availability of the GlycoKnow Ovarian laboratory-developed test through Aranscia’s clinical workflow and technology platforms.
Read More
Allarity Secures US Patent for Ovarian Cancer Companion Diagnostic Test
The patent covers a gene-expression profiling method designed to identify patients most likely to respond to the investigational therapy stenoparib through 2042.
Read More
HerAnova Presents Validation Data for Endometriosis Blood Test
HerAnova Lifesciences presented validation data for HerResolve, a blood-based endometriosis test, showing 94.4% accuracy and detection of cases missed by imaging.
Read More
National Coverage Agreement Secured for Cerebrospinal Fluid Cancer Test
CNSide Diagnostics has secured a national agreement with Elevance Health, expanding access to its CSF Tumor Cell Enumeration assay to 45.4 million more people in the US, Plus Therapeutics announced.
Read More
GRAIL Secures $110 Million Investment from Samsung
GRAIL secured $110 million in equity financing from Samsung affiliates to support U.S. regulatory efforts and expand its Galleri multi-cancer early detection test into Asian markets, the companies announced.
Read More
Countable Labs and Promega Partner for Sample Preparation and Rare Variant Detection
The agreement combines extraction and PCR technologies to create an end-to-end workflow for DNA and RNA analysis.
Read More
Tecan and NVIDIA Integrate New Artificial Intelligence Capabilities into Lab Analytics Platform
Tecan has integrated agentic AI, powered by NVIDIA’s BioNeMo Agent Toolkit, into its Introspect laboratory analytics platform to enable proactive operations and improve productivity in clinical labs.
Read More
Quest Gains New York Approval for Haystack MRD Cancer Monitoring Test
The approval allows Quest Diagnostics to offer its minimal residual disease test for patients in all 50 states.
Read More
Early Lung Cancer Blood Test Completes US Laboratory Validation
The CIZ1B biomarker assay is designed to complement LDCT screening by helping assess lung cancer risk and clarify indeterminate findings.
Read More
Agilent Partners with OpenAI and BCG to Advance Artificial Intelligence in Lab Workflows
Agilent Technologies has partnered with OpenAI and Boston Consulting Group to accelerate artificial intelligence deployment in lab workflows, aiming to deliver faster scientific insights and advance intelligent instruments, software, and services.
Read More
Labcorp Expands DPYD Test to Identify Chemotherapy Toxicity Risk
The updated test includes additional DPYD variants recommended by the Association for Molecular Pathology to help identify patients who may be at risk for severe chemotherapy side effects.
Read More
Tempus Launches Open-Source Digital Pathology Consortium with Major Medical Centers
The initiative aims to standardize digital pathology through an open-source platform and image management system.
Read More
Diazyme Laboratories Acquires Carolina Liquid Chemistries
Diazyme Laboratories has acquired Carolina Liquid Chemistries, integrating CLC’s chemistry systems and reagents with Diazyme’s diagnostic technologies to expand solutions for reference and clinical laboratories.
Read More
Thermo Fisher Scientific Launches New DNA and RNA Analysis System
The integrated electrophoresis solution is designed to simplify routine verification by eliminating gel casting and buffer preparation.
Read More